NIH SEED — Small Business Education and Entrepreneurial Development

Administers small business innovation support across life science agencies, from early proof-of-concept through commercialization planning.

NIH SEED, short for Small Business Education and Entrepreneurial Development, is the NIH-wide coordination office for small-business innovation funding inside the NIH Office of Extramural Research. It coordinates the SBIR and STTR system across 24 NIH institutes and centers and supports related HHS contract solicitations. The office oversees more than $1.4 billion a year in non-dilutive R&D support, making it the main federal coordination point for early-stage life sciences company support.

SEED's operating tools include SBIR and STTR grants and contracts, the Commercialization Readiness Pilot, the Small Business Transition Grant for New Entrepreneurs, and SBIR contract solicitations. The programs in the portfolio reach up to about $4.19 million for CRP, $2.15 million for SBIR/STTR, and about $323,000 for the transition grant. SEED also backs product-development support such as needs assessment, I-Corps, and consulting, so the route is not just money but a commercialization system that helps teams move from discovery to a product plan.

The office is best suited to small businesses that can show a credible translational path, a clear product hypothesis, and the ability to use milestone-driven support. Because awards are made through individual institutes and centers, applicants need to match the science to the right NIH home rather than treat SEED as a standalone awarding office. The portfolio is strongest where the company can pair biomedical novelty with customer discovery, regulatory thinking, and a realistic development plan.